Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Exhaled nitric oxide after high-intensity exercise at 2800 m altitude.

Stang J, Bråten V, Caspersen C, Thorsen E, Stensrud T.

Clin Physiol Funct Imaging. 2015 Sep;35(5):338-43. doi: 10.1111/cpf.12131. Epub 2014 Jan 22.

PMID:
24451001
2.

Exhaled nitric oxide and lung function after moderate normobaric hyperoxic exposure.

Caspersen C, Stensrud T, Storebø M, Thorsen E.

Undersea Hyperb Med. 2013 Jan-Feb;40(1):7-13.

PMID:
23397863
3.

Exhaled nitric oxide concentration upon acute exposure to moderate altitude.

Caspersen C, Stang J, Thorsen E, Stensrud T.

Scand J Med Sci Sports. 2013 Mar;23(2):e102-7. doi: 10.1111/sms.12018. Epub 2012 Nov 16.

PMID:
23157566
4.

Bronchial nitric oxide flux and alveolar nitric oxide concentration after exposure to hyperoxia.

Caspersen C, Stensrud T, Thorsen E.

Aviat Space Environ Med. 2011 Oct;82(10):946-50.

PMID:
21961398
5.

Added mass in human swimmers: age and gender differences.

Caspersen C, Berthelsen PA, Eik M, Pâkozdi C, Kjendlie PL.

J Biomech. 2010 Aug 26;43(12):2369-73. doi: 10.1016/j.jbiomech.2010.04.022. Epub 2010 May 23.

PMID:
20546755
6.

Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency.

Mbaya E, Oulès B, Caspersen C, Tacine R, Massinet H, Pennuto M, Chrétien D, Munnich A, Rötig A, Rizzuto R, Rutter GA, Paterlini-Bréchot P, Chami M.

Cell Death Differ. 2010 Dec;17(12):1855-66. doi: 10.1038/cdd.2010.51. Epub 2010 May 21.

7.

Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.

Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gomez T, Li Q, Caspersen C, Ramasamy R.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H333-41. doi: 10.1152/ajpheart.01012.2008. Epub 2008 Dec 5.

8.

Systemic hyperthermia induces ischemic brain injury in neonatal mice with ligated carotid artery and jugular vein.

Slinko S, Caspersen C, Ratner V, Kim JJ, Alexandrov P, Polin R, Ten VS.

Pediatr Res. 2007 Jul;62(1):65-70.

PMID:
17515843
9.

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

Perier C, Tieu K, Guégan C, Caspersen C, Jackson-Lewis V, Carelli V, Martinuzzi A, Hirano M, Przedborski S, Vila M.

Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19126-31. Epub 2005 Dec 19.

10.

Upregulation of RAGE and its ligands in proliferative retinal disease.

Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.

Exp Eye Res. 2006 May;82(5):807-15. Epub 2005 Dec 20.

PMID:
16364297
11.

Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD.

FASEB J. 2005 Dec;19(14):2040-1. Epub 2005 Oct 6.

PMID:
16210396
12.

C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice.

Ten VS, Sosunov SA, Mazer SP, Stark RI, Caspersen C, Sughrue ME, Botto M, Connolly ES Jr, Pinsky DJ.

Stroke. 2005 Oct;36(10):2244-50. Epub 2005 Sep 22.

PMID:
16179576
13.

L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.

Tieu K, Perier C, Vila M, Caspersen C, Zhang HP, Teismann P, Jackson-Lewis V, Stern DM, Yan SD, Przedborski S.

Ann Neurol. 2004 Jul;56(1):51-60.

PMID:
15236401
14.

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H.

Science. 2004 Apr 16;304(5669):448-52.

15.

D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.

Tieu K, Perier C, Caspersen C, Teismann P, Wu DC, Yan SD, Naini A, Vila M, Jackson-Lewis V, Ramasamy R, Przedborski S.

J Clin Invest. 2003 Sep;112(6):892-901.

16.

The sarco/endoplasmic reticulum calcium-ATPase 2b is an endoplasmic reticulum stress-inducible protein.

Caspersen C, Pedersen PS, Treiman M.

J Biol Chem. 2000 Jul 21;275(29):22363-72.

17.

ACTA, a fluorescent analogue of thapsigargin, is a potent inhibitor and a conformational probe of skeletal muscle Ca2+-ATPase.

Procida K, Caspersen C, Kromann H, Christensen SB, Treiman M.

FEBS Lett. 1998 Nov 13;439(1-2):127-32.

18.

A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases.

Treiman M, Caspersen C, Christensen SB.

Trends Pharmacol Sci. 1998 Apr;19(4):131-5. Review.

PMID:
9612087
19.

Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association.

Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Sivarajan Froelicher ES, Froelicher VF, Pina IL, Pollock ML.

Circulation. 1996 Aug 15;94(4):857-62. No abstract available.

PMID:
8772712

Supplemental Content

Loading ...
Support Center